BRD9P2

Across TCGA pan-cancer cohorts, BRD9P2 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated BRD9P2 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher BRD9P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated BRD9P2 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUAD show a favorable association.

UVM, HNSC, and LUAD are the cancer types where BRD9P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Median	All	0.360	0.834	<.001	143	view →
HNSC	DFS	Quartile	IV	0.726	0.449	<.001	107	view →
LUAD	OS	Quartile	All	0.879	0.736	<.001	73	view →
COAD	DFS	Tertile	II,III,IV	0.487	0.719	<.001	60	view →
SKCM	OS	Tertile	All	0.266	0.395	.002	42	view →
LGG	OS	Median	All	0.522	0.377	<.001	37	view →
ESCA	DFS	Tertile	II,III,IV	0.125	0.860	.005	30	view →
ACC	DFS	Quartile	II,III,IV	0.079	0.533	.018	24	view →
KIRC	OS	Median	All	0.901	0.846	.006	23	view →
CHOL	DFS	Quartile	II,III,IV	0.103	0.540	.004	21	view →
BRCA	DFS	Tertile	III,IV	0.926	0.825	.010	19	view →
THCA	DFS	Median	III,IV	0.379	0.730	.012	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

BRD9P2–UVM (DFS)

Open the UVM breakdown →